Login to Your Account


'Disappointing, but not surprising'

Cowen and Co. analyst Eric Schmidt summed up the consensus of analysts on the phase III failure of Ultragenyx Pharmaceutical Inc. candidate aceneuramic acid extended release in patients with GNE myopathy as "disappointing, but not surprising." more »


Our Habitat for All Things Science
Nuclear factor controlling brown fat gene identified

A study reported Aug. 14, 2017 in Nature Cell Biology has identified a nuclear factor involved in brown fat metabolism that contributes to the pathophysiology of obesity in humans, which could lead to the development of new brown fat-targeted anti-obesity therapies.

The world's population is experiencing an epidemic of obesity and complications including diabetes and atherosclerosis. The World Health Organization estimates that global obesity more than doubled between 1980 and 2014, with almost 2 billion adults being overweight in 2015.

READ MORE »

Opinion


Partners in Focus